+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tenormine"

Tenormine - API Insight, 2022 - Product Thumbnail Image

Tenormine - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Tenormine- Drug Insight, 2019 - Product Thumbnail Image

Tenormine- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Tenormine market is a segment of the cardiovascular drugs industry that focuses on the production and distribution of drugs used to treat hypertension. These drugs are used to reduce high blood pressure, which can lead to serious health complications such as stroke, heart attack, and kidney failure. Tenormine drugs are typically prescribed to patients who have been diagnosed with hypertension, and are often taken in combination with other medications. The market is highly competitive, with a wide range of products available from different manufacturers. The Tenormine market is also characterized by a high degree of innovation, with new drugs and formulations being developed to meet the needs of patients. Many of these drugs are available in generic form, allowing for greater affordability and access to treatment. Some of the major companies in the Tenormine market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. These companies produce a variety of Tenormine drugs, ranging from generic versions to more specialized formulations. Show Less Read more